Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes
Affiliations
- PMID: 2575315
Item in Clipboard
Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes
Acta Biochim Biophys Hung.
1989.
Abstract
Specific binding of (3H) naloxone to opioid receptors in frog (Rana esculenta) brain membranes was irreversibly inactivated by the sulfhydryl group alkylating agent N-ethylmaleimide (NEM). Saturation analysis of (3H) naloxone binding revealed a marked reduction in the number of ligand binding sites after N-ethylmaleimide treatment. Pretreatment of the membranes with unlabelled opioid ligands, i.e. naloxone, morphine, or the kappa selective dynorphin (1-13), and sodium ions resulted in considerable protection of (3H) naloxone binding against the N-ethylmaleimide blockade.
Similar articles
-
Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain.J Neurochem. 1988 Sep;51(3):736-9. doi: 10.1111/j.1471-4159.1988.tb01806.x. J Neurochem. 1988. PMID: 2900875
-
Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.J Pharmacol Exp Ther. 1986 Nov;239(2):351-7. J Pharmacol Exp Ther. 1986. PMID: 3021954
-
Inactivation of kappa opioid receptors by N-ethylmaleimide.Prog Clin Biol Res. 1990;328:89-92. Prog Clin Biol Res. 1990. PMID: 2154825 No abstract available.
-
Opium alkaloids and affinity labels.NIDA Res Monogr. 1990;96:21-34. NIDA Res Monogr. 1990. PMID: 2172823 Review. No abstract available.
-
Influence of morphine on membrane turnover and function.Adv Biochem Psychopharmacol. 1979;20:495-520. Adv Biochem Psychopharmacol. 1979. PMID: 224661 Review. No abstract available.